Yifeng Pharmacy Chain Balance Sheet Health
Financial Health criteria checks 5/6
Yifeng Pharmacy Chain has a total shareholder equity of CN¥10.9B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 29.9%. Its total assets and total liabilities are CN¥27.2B and CN¥16.3B respectively. Yifeng Pharmacy Chain's EBIT is CN¥2.2B making its interest coverage ratio 55.6. It has cash and short-term investments of CN¥8.1B.
Key information
29.9%
Debt to equity ratio
CN¥3.26b
Debt
| Interest coverage ratio | 55.6x |
| Cash | CN¥8.06b |
| Equity | CN¥10.90b |
| Total liabilities | CN¥16.31b |
| Total assets | CN¥27.21b |
Recent financial health updates
Recent updates
Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled
Dec 12
We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings
Nov 06The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More
Sep 27Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)
Jul 29Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch
Jun 20Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly
May 24Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors
May 06Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?
Apr 13Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings
Mar 28Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price
Mar 13Financial Position Analysis
Short Term Liabilities: 603939's short term assets (CN¥14.7B) exceed its short term liabilities (CN¥12.3B).
Long Term Liabilities: 603939's short term assets (CN¥14.7B) exceed its long term liabilities (CN¥4.0B).
Debt to Equity History and Analysis
Debt Level: 603939 has more cash than its total debt.
Reducing Debt: 603939's debt to equity ratio has increased from 16.7% to 29.9% over the past 5 years.
Debt Coverage: 603939's debt is well covered by operating cash flow (156%).
Interest Coverage: 603939's interest payments on its debt are well covered by EBIT (55.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 17:06 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yifeng Pharmacy Chain Co., Ltd. is covered by 23 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ethan Cui | BofA Global Research |
| Hao Wu | Chasing Securities |
| Qianyi Li | China International Capital Corporation Limited |